about
Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myelomaNovel insights into the mechanism of action of lenalidomide.The role of Dickkopf-1 as a potential prognostic marker in pancreatic ductal adenocarcinoma.MMSA-1 expression pattern in multiple myeloma and its clinical significance.
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
DKK1 as a novel target for myeloma immunotherapy.
@en
DKK1 as a novel target for myeloma immunotherapy.
@nl
type
label
DKK1 as a novel target for myeloma immunotherapy.
@en
DKK1 as a novel target for myeloma immunotherapy.
@nl
prefLabel
DKK1 as a novel target for myeloma immunotherapy.
@en
DKK1 as a novel target for myeloma immunotherapy.
@nl
P2860
P356
P1433
P1476
DKK1 as a novel target for myeloma immunotherapy.
@en
P2093
P2860
P304
P356
10.4161/ONCI.19655
P577
2012-08-01T00:00:00Z